Current Environment: Production

Tom Rosenberg | Education

Medical School

Ben Gurion University

2010, Beer Sheva, Israel

Residency

2017

Tel Aviv Medical Center

Pediatrics, Tel Aviv, Israel

Fellowship

Pediatric Hematology/Oncology

Tel Aviv Medical Center

2020, Tel Aviv, Israel

Fellowship

Pediatric Neuro-Oncology

Dana-Farber/Boston Children's Cancer and Blood Disorders Center

2021, Boston, MA

Tom Rosenberg | Publications

  1. Dissecting the immune landscape in pediatric high-grade glioma reveals cell state changes under therapeutic pressure. Cell Rep Med. 2025 May 20; 6(5):102095. View Dissecting the immune landscape in pediatric high-grade glioma reveals cell state changes under therapeutic pressure. Abstract

  2. Current Open Trials and Molecular Update for Pediatric Embryonal Tumors. Pediatr Neurosurg. 2023; 58(5):299-306. View Current Open Trials and Molecular Update for Pediatric Embryonal Tumors. Abstract

  3. Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor. Neoplasia. 2023 03; 37:100880. View Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor. Abstract

  4. Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics. Neuro Oncol. 2023 01 05; 25(1):199-210. View Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics. Abstract

  5. Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma. Neuro Oncol. 2022 11 02; 24(11):1964-1975. View Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma. Abstract

  6. Molecular genetics of paediatric brain tumours and opportunities for precision medicine - a focus on infant tumours. Curr Opin Neurol. 2022 12 01; 35(6):772-778. View Molecular genetics of paediatric brain tumours and opportunities for precision medicine - a focus on infant tumours. Abstract

BESbswy